CD8A and hepatocellular carcinoma: One possible explanation that researchers uncovered in immunotherapy-resistant HCC murine models is that tumor cell intrinsic upregulation of PPARγ transcriptionally activated VEGF-A production, which drove MDSC expansion and CD8+ T cell dysfunction [50].